{"id":44683,"date":"2025-10-15T12:09:07","date_gmt":"2025-10-15T04:09:07","guid":{"rendered":"https:\/\/www.1ai.net\/?p=44683"},"modified":"2025-10-15T12:09:07","modified_gmt":"2025-10-15T04:09:07","slug":"%e5%8c%b9%e5%85%b9%e5%a0%a1%e3%80%81%e5%93%88%e4%bd%9b%e3%80%81%e6%96%af%e5%9d%a6%e7%a6%8f%e7%ad%89%e9%ab%98%e6%a0%a1%e6%95%99%e6%8e%88%e8%ad%a6%e5%91%8a%ef%bc%9aai-%e6%88%96%e4%bd%bf%e5%8c%bb","status":"publish","type":"post","link":"https:\/\/www.1ai.net\/en\/44683.html","title":{"rendered":"PROFESSORS OF PITTSBURGH, HARVARD, STANFORD, AND OTHERS WARNED THAT AI MIGHT MAKE MEDICAL ACCIDENTS MORE DIFFICULT TO DETERMINE"},"content":{"rendered":"<p>On October 15, according to the British Guardian, 13, several experts warned<a href=\"https:\/\/www.1ai.net\/en\/tag\/ai\" title=\"[View articles tagged with [AI]]\" target=\"_blank\" >AI<\/a> Application in the medical field may raise complex questions of legal liability, and when medical errors occur, the determination of liability may become confused\u3002<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-44684\" title=\"65772b51j00t45nho002md000qf00nfp\" src=\"https:\/\/www.1ai.net\/wp-content\/uploads\/2025\/10\/65772b51j00t45nho002md000qf00nfp.jpg\" alt=\"65772b51j00t45nho002md000qf00nfp\" width=\"951\" height=\"843\" \/><\/p>\n<p>CLINICAL AI HAS DEVELOPED RAPIDLY, AND RESEARCHERS HAVE DEVELOPED A VARIETY OF TOOLS, RANGING FROM ALGORITHMS THAT AID IMAGE INTERPRETATION TO SYSTEMS THAT SUPPORT DIAGNOSIS, TO AI. AI IS ALSO BEING APPLIED TO HOSPITAL MANAGEMENT, FROM OPTIMIZING THE USE OF BEDS TO IMPROVING SUPPLY CHAIN EFFICIENCY\u3002<\/p>\n<p>EXPERTS POINTED OUT THAT AI HAD CONCERNS ABOUT THE MULTIPLE BENEFITS THAT WERE EXPECTED, INCLUDING:<strong>The validity of the tool has not yet been fully validated<\/strong>,as well as<strong>It is difficult to define the attribution of responsibility in the event of adverse results<\/strong>.<\/p>\n<p>PROFESSOR DEREK ANGUS OF THE UNIVERSITY OF PITTSBURGH SAID: \u201cTHERE MUST BE A SITUATION IN WHICH A PROBLEM IS PERCEIVED AND AN ATTEMPT IS MADE TO FIND THE RESPONSIBLE PARTY.\u201d ANGUS WAS THE FIRST AUTHOR OF THE REPORT OF THE AI SUMMIT ORGANIZED LAST YEAR BY THE AMERICAN MEDICAL ASSOCIATION MAGAZINE. THE REPORT ANALYSES NOT ONLY THE CHARACTERISTICS AND AREAS OF APPLICATION OF THE AI TOOL, BUT ALSO THE LEGAL CHALLENGES IT POSES\u3002<\/p>\n<p>PROFESSOR GLENN COHEN OF HARVARD LAW SCHOOL, CO-AUTHOR OF THE REPORT, STATED THAT PATIENTS MAY EXPERIENCE DIFFICULTIES IN PROVING FAULT IN THE USE OR DESIGN OF AI PRODUCTS. ON THE ONE HAND<strong>Hard to get in-house running information on the tool<\/strong>On the other hand<strong>IT IS DIFFICULT TO PROPOSE A REASONABLE ALTERNATIVE DESIGN OR TO PROVE THAT THE NEGATIVE RESULT IS CAUSED BY AI<\/strong>I don't know. According to Professor Cohen: \u201cThe parties may abdicate each other's responsibility and may, by contract, redistribute responsibility or involve litigation for damages, which may make it more difficult to bring an action.\u201d<\/p>\n<p>PROFESSOR MICHEL MELO OF STANFORD LAW SCHOOL, WHO WAS ONE OF THE AUTHORS OF THE REPORT, SAID THAT THE COURTS WERE ABLE TO RESOLVE RELEVANT LEGAL ISSUES, BUT THAT EARLY PROCESSING WAS TIME-CONSUMING AND UNCERTAIN, INCREASING THE OVERALL COST OF AI INNOVATION AND APPLICATION OF ECOSYSTEMS. \u201cTHIS UNCERTAINTY INCREASES THE COST OF AI INNOVATION AND APPLICATION.\u201d<\/p>\n<p>Report<strong>CONCERNS WERE RAISED ABOUT THE EVALUATION OF THE AI TOOL<\/strong>IT WAS NOTED THAT MANY TOOLS WERE NOT MONITORED BY REGULATORY BODIES SUCH AS THE UNITED STATES FOOD AND DRUG REGULATORY AUTHORITY. ANGUS STATED: \u201cCLINICIANS ARE CONCERNED WITH IMPROVING HEALTH OUTCOMES, BUT REGULATORS DO NOT NECESSARILY REQUIRE PROOF. ONCE IN USE, AI TOOLS MAY APPEAR IN DIFFERENT CLINICAL SETTINGS, FACE DIFFERENT PATIENTS AND BE OPERATED BY USERS WITH DIFFERENT SKILL LEVELS<strong>Unforeseeable situations<\/strong>I don't know. The practical use of seemingly feasible tools at the approval stage may vary considerably.\u201d<\/p>\n<p>1AI WAS INFORMED FROM THE REPORT THAT THE REPORT ALSO INDICATES THAT THERE ARE MULTIPLE BARRIERS TO THE ASSESSMENT OF THE AI TOOLS, SUCH AS<strong>It usually takes clinical use to make a full assessment<\/strong>THE CURRENT ASSESSMENT IS EXPENSIVE AND CUMBERSOME. ANGUS EMPHASIZED THE NEED TO INVEST IN A FULL ASSESSMENT OF THE AI TOOLS IN HEALTH CARE AND THE FOCUS ON BUILDING DIGITAL INFRASTRUCTURE. \u201cTHE SUMMIT DISCUSSIONS FOUND THAT THE MOST ADEQUATE TOOLS ARE OFTEN THE LEAST USED AND THE MOST WIDELY AVAILABLE TOOLS ARE THE LEAST EVALUATED.\u201d<\/p>","protected":false},"excerpt":{"rendered":"<p>ON OCTOBER 15, ACCORDING TO THE BRITISH GUARDIAN, SEVERAL EXPERTS WARNED THAT THE APPLICATION OF AI IN THE MEDICAL FIELD COULD RAISE COMPLEX LEGAL LIABILITY ISSUES AND THAT WHEN MEDICAL ERRORS OCCUR, THE DETERMINATION OF LIABILITY MAY BECOME CONFUSED. CLINICAL AI HAS DEVELOPED RAPIDLY, AND RESEARCHERS HAVE DEVELOPED A VARIETY OF TOOLS, RANGING FROM ALGORITHMS THAT AID IMAGE INTERPRETATION TO SYSTEMS THAT SUPPORT DIAGNOSIS, TO AI. AI IS ALSO BEING APPLIED TO HOSPITAL MANAGEMENT, FROM OPTIMIZING THE USE OF BEDS TO IMPROVING SUPPLY CHAIN EFFICIENCY. EXPERTS NOTED THAT AI HAD CONCERNS ABOUT THE MANY BENEFITS THAT IT WAS EXPECTED TO BRING, INCLUDING THE FACT THAT THE EFFECTIVENESS OF THE TOOL WAS NOT YET FULLY VALIDATED AND THAT, IN THE EVENT OF ADVERSE RESULTS FOR PATIENTS, THE ATTRIBUTION OF RESPONSIBILITY WAS DIFFICULT TO DEFINE. PROFESSOR DEREK ANGUS OF THE UNIVERSITY OF PITTSBURGH SAID, \"THERE'S GOTTA BE A PROBLEM<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[146],"tags":[411,3308],"collection":[],"class_list":["post-44683","post","type-post","status-publish","format-standard","hentry","category-news","tag-ai"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.1ai.net\/en\/wp-json\/wp\/v2\/posts\/44683","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.1ai.net\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.1ai.net\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.1ai.net\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.1ai.net\/en\/wp-json\/wp\/v2\/comments?post=44683"}],"version-history":[{"count":0,"href":"https:\/\/www.1ai.net\/en\/wp-json\/wp\/v2\/posts\/44683\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.1ai.net\/en\/wp-json\/wp\/v2\/media?parent=44683"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.1ai.net\/en\/wp-json\/wp\/v2\/categories?post=44683"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.1ai.net\/en\/wp-json\/wp\/v2\/tags?post=44683"},{"taxonomy":"collection","embeddable":true,"href":"https:\/\/www.1ai.net\/en\/wp-json\/wp\/v2\/collection?post=44683"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}